ESLA ▲ +62.5% - Estrella Immunopharma, Inc.
$ESLA - Estrella Immunopharma Treats First Patient with Two EB103 Infusions in STARLIGHT-1 Dose-Expansion Phase
15-OCT-2026 06:46 PM ET
Share this post
More filings for $ESLA
ESLA ▲ +3.2% - Estrella Immunopharma, Inc.Oct 14, 2026ESLA - Estrella Immunopharma, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $ESLA filing history →💬 Comments
Loading comments…
Leave a comment